Clinical Studies on GLP-1 Agonists in Breast Cancer Patients Three recent analyses summarized in abstracts have reviewed the use of GLP-1 RAs for weight management in BC patients, with varying results
Purchasing Outside of the Plan Heres how members can get their hands on GLP-1s without using their health plan, from the least to most regulated: Medical Spas (also known as Med Spas) Given directly by a med spa provider Less regulated, making it harder to assess quality and safety Members should ask about the manufacturing source and verify all active/inactive ingredients Compounding Pharmacies Requires a prescription or tele-health provider approval There are two types that differ in regulatory oversight and manufacturing standards: 503A: Traditional compounding pharmacies that prepare meds for an individual patient 503B: FDA-regulated outsourcing facilities that produce large batches of meds for office use or healthcare facilities Example : HIMS offers options starting at $165/month Direct Manufacturer Purchase Requires a providers prescription Example : Through Lilly-Direct, Zepbound costs as little as $25/month (with commercial insurance) or $399/month (without commercial insurance) Cash Price + Manufacturer Coupon Requires a prescription Available at any pharmacy Prices vary based on drug, location and availability Purchasing Using Insurance Obtain a prescription for an FDA-approved weight loss GLP-1 (Saxenda, Zepbound, or Wegovy)
About every four weeks, your healthcare provider may gradually raise your dose by around 0.5 milligrams until you reach the maintenance dose of 2.4 milligrams
When the data of both the groups were combined, changes in d-ROMs were significantly correlated with HbA1c ( r = 0.338, p = 0.040), MGL ( r = 0.349, p = 0.034), SD ( r = 0.430, p = 0.008), MAGE ( r = 0.333, p = 0.044), CV ( r = 0.325, p = 0.050), TAR ( r = 0.373, p = 0.023), and TIR ( r = 0.404, p = 0.013) values in the univariate analysis
